Schroeder Thilo's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Mar 24, 2022
- Accession no.
- 0001209191-22-020984
- Filed
- Mar 24, 2022
- Trade date
- Mar 22-24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market purchases total $5.49M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 | Common Stock | PPurchaseAcquired | +5,440 | $22.15 | +$120,496 | 701,666 | Indirect | |
| Mar 22, 2022 | Common Stock | PPurchaseAcquired | +71,186 | $23.18 | +$1,650,091.48 | 772,852 | Indirect | |
| Mar 22, 2022 | Common Stock | PPurchaseAcquired | +53,501 | $23.69 | +$1,267,438.69 | 826,353 | Indirect | |
| Mar 23, 2022 | Common Stock | PPurchaseAcquired | +37,708 | $23.61 | +$890,285.88 | 864,061 | Indirect | |
| Mar 23, 2022 | Common Stock | PPurchaseAcquired | +15,410 | $23.99 | +$369,685.9 | 879,471 | Indirect | |
| Mar 24, 2022 | Common Stock | PPurchaseAcquired | +49,119 | $24.26 | +$1,191,626.94 | 928,590 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.